Mobic (Page 8 of 8)

PRINCIPAL DISPLAY PANEL — 7.5 mg Tablet Bottle Label

NDC 0597-0029-01

ATTENTION DISPENSER:
Dispense with accompanying
Medication Guide.

Mobic®
(meloxicam tablets)

7.5 mg
100 tablets

Dosage: Read accompanying
prescribing information.

Rx only

Boehringer Ingelheim

PRINCIPAL DISPLAY PANEL -- 7.5 mg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 15 mg Tablet Bottle Label

NDC 0597-0030-01

ATTENTION DISPENSER:
Dispense with accompanying
Medication Guide.

Mobic®
(meloxicam) tablets

15 mg
100 tablets

Dosage: Read accompanying
prescribing information.

Rx only

Boehringer Ingelheim

PRINCIPAL DISPLAY PANEL -- 15 mg Tablet Bottle Label
(click image for full-size original)
MOBIC meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0597-0029
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 7.5 mg
Product Characteristics
Color YELLOW Score no score
Shape ROUND Size 8mm
Flavor Imprint Code M;
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0597-0029-01 100 TABLET in 1 BOTTLE, PLASTIC None
2 NDC:0597-0029-94 10 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020938 06/25/2001 09/30/2022
MOBIC meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0597-0030
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 15 mg
Product Characteristics
Color YELLOW Score no score
Shape OVAL (Oblong) Size 11mm
Flavor Imprint Code M;15
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0597-0030-01 100 TABLET in 1 BOTTLE, PLASTIC None
2 NDC:0597-0030-56 10 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020938 10/01/2000 09/30/2022
Labeler — Boehringer Ingelheim Pharmaceuticals, Inc. (603175944)
Registrant — Boehringer Ingelheim Pharmaceuticals, Inc. (603175944)
Establishment
Name Address ID/FEI Operations
Boehringer Ingelheim Promeco, S.A. de C.V. 812579472 PACK (0597-0029), PACK (0597-0030), ANALYSIS (0597-0029), ANALYSIS (0597-0030), LABEL (0597-0029), LABEL (0597-0030), MANUFACTURE (0597-0029), MANUFACTURE (0597-0030)
Establishment
Name Address ID/FEI Operations
Boehringer Ingelheim Pharma GmbH and Co. KG 551147440 ANALYSIS (0597-0029), ANALYSIS (0597-0030), MANUFACTURE (0597-0029), MANUFACTURE (0597-0030), API MANUFACTURE (0597-0029), API MANUFACTURE (0597-0030), PACK (0597-0029), PACK (0597-0030), LABEL (0597-0029), LABEL (0597-0030)
Establishment
Name Address ID/FEI Operations
Bidachem S.p.a. 429232812 ANALYSIS (0597-0029), ANALYSIS (0597-0030), API MANUFACTURE (0597-0029), API MANUFACTURE (0597-0030)
Establishment
Name Address ID/FEI Operations
Boehringer Ingelheim Pharma GmbH and Co. KG 340700520 ANALYSIS (0597-0029), ANALYSIS (0597-0030), API MANUFACTURE (0597-0029), API MANUFACTURE (0597-0030)

Revised: 10/2018 Boehringer Ingelheim Pharmaceuticals, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.